Scientists track breast Cancer's genetic evolution in recurrence study
NCT ID NCT02530008
First seen Jan 22, 2026 · Last updated May 14, 2026 · Updated 16 times
Summary
This study follows 600 women whose breast cancer has returned to learn how the cancer changes over time. Participants give blood and tumor samples, but no new treatments are tested. The goal is to find genetic markers that could guide future therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WOMEN WITH SUSPECTED OR CONFIRMED RECURRENT BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Lancaster General Hospital
Lancaster, Pennsylvania, 17602, United States
Conditions
Explore the condition pages connected to this study.